Arcarios is a drug development company dedicated to the discovery and development of innovative products in the field of bone and joint diseases such as osteoporosis and osteoarthritis.

Current treatment options are insufficient and indicate an urgent need for disease modifying drugs. The company’s proprietary technology platform allows for the successful development of treatments focussed on restoring cartilage and bone, thereby addressing an important unmet medical need in today’s society.

Having two advanced therapeutic programs with a strong technology and IP position, Arcarios is well positioned to capitalize on the market opportunity in the field of osteoarthritis and osteoporosis.